Deep, specific next-era sequencing has discovered that subclonal mutations (i.e., These current in just a fraction of tumor cells) might be detected for all driver genes and so are associated with rapid disease development and poor outcome.eleven–13 This is particularly pertinent for TP53The scientific study course of CLL is rather heterogeneous,